PubRank

Anna Jakubowska

Author PubWeight™ 138.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
2 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
3 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
4 Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010 4.51
5 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
6 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
7 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
8 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
9 RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007 3.63
10 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
11 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
12 A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 2008 2.43
13 Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013 2.39
14 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
15 Lower airway papillomatosis in children. Int J Pediatr Otorhinolaryngol 2003 2.11
16 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 2.09
17 The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004 2.01
18 A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004 1.96
19 Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 2011 1.94
20 Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013 1.88
21 AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev 2007 1.75
22 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
23 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
24 Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010 1.41
25 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
26 Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res 2012 1.38
27 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
28 A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 2006 1.34
29 Hereditary ovarian cancer in Poland. Int J Cancer 2003 1.30
30 Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2013 1.29
31 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
32 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
33 Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011 1.17
34 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
35 Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 2003 1.13
36 Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011 1.12
37 Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. Carcinogenesis 2008 1.04
38 The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract 2005 1.04
39 BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev 2008 1.01
40 German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur J Cancer 2005 1.00
41 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
42 A low selenium level is associated with lung and laryngeal cancers. PLoS One 2013 0.99
43 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
44 Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 2012 0.98
45 The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate 2013 0.97
46 Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Breast Cancer Res Treat 2008 0.95
47 Can selenium levels act as a marker of colorectal cancer risk? BMC Cancer 2013 0.93
48 Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 2005 0.92
49 Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer. Breast Cancer Res Treat 2015 0.91
50 The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer 2013 0.91
51 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
52 Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2014 0.89
53 A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012 0.89
54 BRCA1 mutations and colorectal cancer in Poland. Fam Cancer 2010 0.89
55 A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene 2013 0.89
56 A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat 2007 0.89
57 Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One 2011 0.88
58 The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev 2010 0.87
59 CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer 2010 0.87
60 CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat 2006 0.87
61 DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int 2007 0.87
62 Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Hum Genet 2011 0.87
63 Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood. Clin Nephrol 2014 0.87
64 Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Hum Mol Genet 2011 0.85
65 Epistatic relationship between the cancer susceptibility genes CHEK2 and p27. Cancer Epidemiol Biomarkers Prev 2007 0.84
66 Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer. Breast Cancer Res Treat 2014 0.83
67 Molecular basis of inherited predispositions for tumors. Acta Biochim Pol 2002 0.83
68 CYP1B1 and predisposition to breast cancer in Poland. Breast Cancer Res Treat 2007 0.83
69 Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011 0.83
70 Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS One 2010 0.83
71 Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2011 0.83
72 Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res 2003 0.83
73 PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE. Retina 2016 0.82
74 CHEK2-positive breast cancers in young Polish women. Clin Cancer Res 2006 0.82
75 Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. Eur J Cancer Prev 2008 0.81
76 The presence of prostate cancer at biopsy is predicted by a number of genetic variants. Int J Cancer 2013 0.79
77 Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. J Med Genet 2007 0.79
78 Association of MMP8 gene variation with an increased risk of malignant melanoma. Melanoma Res 2011 0.78
79 Polymorphic variants in VAX1 gene (rs7078160) and BMP4 gene (rs762642) and the risk of non-syndromic orofacial clefts in the Polish population. Dev Period Med 2014 0.78
80 Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype. J Hum Genet 2002 0.78
81 Low-risk Genes and Multi-organ Cancer Risk in the Polish Population. Hered Cancer Clin Pract 2006 0.78
82 Water activity in aqueous solutions of homogeneous electrolytes: the effect of ions on the structure of water. Chemphyschem 2002 0.78
83 The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men. Eur J Cancer Prev 2015 0.77
84 Breast cancer susceptibility genes. J BUON 2007 0.77
85 New investigational drugs for the treatment of neuropathic pain. Expert Opin Investig Drugs 2014 0.77
86 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
87 Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study. Cancer Causes Control 2012 0.77
88 Cebranopadol : a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors. Expert Opin Investig Drugs 2015 0.76
89 GH3 expression and IAA-amide synthetase activity in pea (Pisum sativum L.) seedlings are regulated by light, plant hormones and auxinic herbicides. J Plant Physiol 2013 0.76
90 Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? Mutagenesis 2013 0.76
91 Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat 2014 0.75
92 Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomas. Hered Cancer Clin Pract 2004 0.75
93 Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours. Hered Cancer Clin Pract 2004 0.75
94 Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2015 0.75
95 Coverage of the genetic background of breast cancer in the polish population. Hered Cancer Clin Pract 2006 0.75
96 Zucapsaicin for the treatment of neuropathic pain. Expert Opin Investig Drugs 2014 0.75
97 DNA and RNA analyses in detection of genetic predisposition to cancer. Hered Cancer Clin Pract 2012 0.75
98 Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Res Treat 2012 0.75
99 Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer Inst 2017 0.75
100 Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 2016 0.75
101 Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort. Anticancer Res 2008 0.75
102 Fine needle aspiration biopsy and molecular analysis in differential diagnosis of lymphoproliferative diseases of the orbit and eye adnexa. Pol J Pathol 2004 0.75
103 Selenium as marker for cancer risk and prevention. Pol Przegl Chir 2012 0.75
104 [Acyltransferases involved in plant secondary metabolism: classification, structure, reaction mechanism]. Postepy Biochem 2015 0.75
105 [Prune-belly syndrome and therapeutic problems]. Pol Merkur Lekarski 2008 0.75
106 Progress in the Search for New Dopamine Transporter Inhibitors. Curr Med Chem 2015 0.75
107 [Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation]. Ginekol Pol 2002 0.75
108 Genotyping by induced Förster Resonance Energy Transfer(iFRET) mechanism and simultaneous mutation scanning. Hum Mutat 2013 0.75
109 Identification of enzyme activity that conjugates indole-3-acetic acid to aspartate in immature seeds of pea (Pisum sativum). J Plant Physiol 2007 0.75
110 Possible association of the BRCA2 gene C5972T variant with gastric cancer: a study on Polish population. Pol Arch Med Wewn 2015 0.75
111 The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2010 0.75
112 Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations. J Appl Genet 2004 0.75
113 Clinical characteristics of hereditary ovarian cancer (HOC) in Poland. Ginekol Pol 2002 0.75
114 The effects of dietary cholesterol on metabolism and daily torpor patterns in Siberian hamsters. Physiol Biochem Zool 2014 0.75
115 Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers. J Appl Genet 2003 0.75